Company profile

Oxehealth

Mental Health & Digital Therapeutics

Company profile

About Oxehealth

LIO (formerly Oxehealth) is a health technology company specializing in intelligent patient monitoring for inpatient mental health facilities. Founded in 2012 at the University of Oxford's Institute of Biomedical Engineering under the leadership of Professor Lord Lionel Tarassenko, the company developed a pioneering approach to contactless patient monitoring that established an entirely new category of health technology. The LIO platform integrates three core capabilities: digital rounding for efficient data collection and protocol adherence, ambient monitoring using ceiling-mounted infrared cameras and AI-powered analysis to provide continuous patient insights without wearables or wires, and compliance reporting that gives leaders visibility into operations and care quality. The system captures vital signs, monitors patient activity, tracks sleep patterns, and provides safety notifications—all through contactless technology that prioritizes patient dignity and privacy. LIO serves mental health providers across the US and UK, with over 100 customer sites and 5,000 installations supporting more than 100 million hours of patient care. The platform has been developed through 15+ years of collaboration with mental health care providers and co-created with patients, carers, clinicians, and leaders. Clinical evidence demonstrates significant improvements in safety outcomes, including 44% reduction in self-harm, 48% decrease in falls, 37% fewer assaults, and 71% reduction in 1:1 observations. The company holds 19 patents and has published over 20 peer-reviewed studies validating its real-world impact.

Company description Oxehealth official website

Primary marketMental Health & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Oxehealth?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Behavioral health acute care
  • Mental health conditions requiring inpatient psychiatric care

Who it serves

  • Behavioral health acute care units
  • Inpatient mental health facilities
  • Psychiatric hospitals

Deployment & integration

Cloud Saas · Hybrid deployment with recorded integration context.

Recorded integration context: All EHR systems (seamless integration claimed).

Geographic context

MarketsUnited Kingdom · United States
Company sourceOfficial website

Company milestones

Platform expansion

Rebranded from Oxehealth to LIO. 50% of NHS mental health trusts now partner with the company. Over 100 customer sites with 5,000 installations supporting 100M+ hours of patient care.

Partnerships

Recorded partners

  • NHS (National Health Service)
  • University of Oxford Institute of Biomedical Engineering

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

LIO

All-in-one platform for inpatient mental health care with digital rounding, ambient monitoring and compliance reporting

Platform · Cloud SaaSCompany source

LIO Ambient Monitoring

Contactless patient monitoring with AI-powered vision technology for mental health safety

Platform · HybridCompany source

LIO Compliance Reporting

Comprehensive compliance dashboards with audit trails and automated reporting for mental health facilities

Software · Cloud SaaSCompany source

LIO Digital Rounding

Fast, intuitive digital rounding with time-stamped data entry and spot-check vitals

Software · Cloud SaaSCompany source

LIO eObs

Electronic observations module for mental health care

Software · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

44% reduction in self-harm

Ndebele et al. 2024, Journal of Mental Health

48% decrease in falls

Wright & Singh 2022, Journal of Patient Safety

37% fewer assaults

Ndebele et al. 2022, Journal of Psychiatric Intensive Care

71% reduction in 1:1 observations

Wright & Singh 2022, Journal of Patient Safety

50% faster observations at night

Buckley et al. 2024, PLOS Digital Health

Mental health providers using LIO (aggregate)

Optimization of 1:1 observation staffing through ambient monitoring technology

71% reduction in 1:1 observations

NHS Mental Health Trusts (aggregate)

Reduction in self-harm incidents through ambient monitoring and digital rounding

44% reduction in self-harm

Inpatient mental health provider (unnamed)

Implementation of LIO platform for equitable, safe and inclusive behavioral health care delivery

Enhanced quality and patient experience with less intrusive and safer care

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

James Ede-Golightly

Chairperson

Glenn Blatz

VP Sales

Sophie Davies

VP of Customer Success and Professional Services

Julian Dixon

VP of Engineering

Ben Walsh

VP Marketing

Charlotte Wood

VP Corporate Development

Danny Rose

Director of Finance

06 · Company updates

Updates from Oxehealth

Recent articles published on Oxehealth's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Mental Health & Digital Therapeutics

Companies providing AI-powered mental health support, therapy platforms, mental wellness tracking, psychiatric care, digital therapeutics for mental health conditions, or AI-driven mental health screening and monitoring. Includes XR-based therapy, AI mental health screening infrastructure, and platforms supporting behavioral health for individuals and health systems.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon